bpc 157 fda status commitee votes 8-6 to make BPC-157 legal. What the FDA briefing report said about the evidence FDA advisory committee recommends BPC-157

The findings are remarkably consistent across studies

The right choice depends on the injury type, location, and your goals

7 BPC-157 has also been shown to improve the healing of segmental bone defects in rabbits, comparable to traditional treatments like bone marrow or autologous cortical grafts

To learn more about Timeline and Mitopure, check out our full Mitopure review

Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded